How do hypertrophic cardiomyopathy mutations affect myocardial function in carriers with normal wall thickness? Assessment with cardiovascular magnetic resonance

Journal of Cardiovascular Magnetic Resonance

Volumn 12, Issue 1, 2010, Pages

  Germans, Tjeerd ^a,b   Rüssel, Iris K ^a   Götte, Marco Jw ^c   Spreeuwenberg, Marieke D ^a   Doevendans, Pieter A ^b,d   Pinto, Yigal M ^b,e   Van Der Geest, Rob J ^f   Van Der Velden, Jolanda ^a   Wilde, Arthur Am ^e   Van Rossum, Albert C ^a,b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

^c HagaZiekenhuis ^*  (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

^f LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM; CONTRAST MEDIUM; DIAGNOSTIC AGENT; GADOLINIUM PENTETATE;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTRAST ENHANCEMENT; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; FUNCTIONAL ASSESSMENT; GENE MUTATION; HEART FUNCTION; HETEROZYGOTE; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MALE; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PRIORITY JOURNAL; TISSUE DOPPLER IMAGING; CASE CONTROL STUDY; DOPPLER ECHOCARDIOGRAPHY; GENETIC PREDISPOSITION; GENETICS; HEART ATRIUM; HEART ATRIUM FUNCTION; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE; MIDDLE AGED; MUTATION; OBSERVER VARIATION; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; PREDICTION AND FORECASTING; REPRODUCIBILITY;

ADULT; ATRIAL FUNCTION, LEFT; CARDIOMYOPATHY, HYPERTROPHIC; CASE-CONTROL STUDIES; CONTRAST MEDIA; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; GADOLINIUM DTPA; GENETIC PREDISPOSITION TO DISEASE; HEART ATRIA; HEART VENTRICLES; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MUTATION; OBSERVER VARIATION; PHENOTYPE; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; VENTRICULAR FUNCTION, LEFT;

EID: 77952526210     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/1532-429X-12-13     Document Type: Article

References (30)

1. Hypertrophic cardiomyopathy: a systematic review. BJ Maron, JAMA 2002 287 1308 1320 10.1001/jama.287.10.1308 11886323
2. Pathogenesis of diverse clinical and pathological phenotypes in hypertrophic cardiomyopathy. AJ Marian, Lancet 2000 355 58 60 10.1016/S0140-6736(99)06187-5 10615904
3. An abnormal Ca(2+) response in mutant sarcomere protein-mediated familial hypertrophic cardiomyopathy. D Fatkin BK McConnell JO Mudd C Semsarian IG Moskowitz FJ Schoen M Giewat CE Seidman JG Seidman, J Clin Invest 2000 106 1351 1359 10.1172/JCI11093 11104788
4. Computational simulation of hypertrophic cardiomyopathy mutations in troponin I: influence of increased myofilament calcium sensitivity on isometric force, ATPase and [Ca2+]i. A Kataoka C Hemmer PB Chase, J Biomech 2007 40 2044 2052 10.1016/j.jbiomech.2006.09.026 17140583
5. A mouse model of familial hypertrophic cardiomyopathy. AA Geisterfer-Lowrance M Christe DA Conner JS Ingwall FJ Schoen CE Seidman JG Seidman, Science 1996 272 731 734 10.1126/science.272.5262.731 8614836
6. Effect of cardiac myosin binding protein-C on mechanoenergetics in mouse myocardium. BM Palmer T Noguchi Y Wang JR Heim NR Alpert PG Burgon CE Seidman JG Seidman DW Maughan MM LeWinter, Circ Res 2004 94 1615 1622 10.1161/01.RES. 0000132744.08754.f2 15155526
7. Cardiac myosin-binding protein C is required for complete relaxation in intact myocytes. L Pohlmann I Kroger N Vignier S Schlossarek E Kramer C Coirault KR Sultan A El-Armouche S Winegrad T Eschenhagen L Carrier, Circ Res 2007 101 928 938 10.1161/CIRCRESAHA.107.158774 17823372
8. Tissue Doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy. SF Nagueh LL Bachinski D Meyer R Hill WA Zoghbi JW Tam MA Quĩones R Roberts AJ Marian, Circulation 2001 104 128 130 11447072
9. Assessment of diastolic function with Doppler tissue imaging to predict genotype in preclinical hypertrophic cardiomyopathy. CY Ho NK Sweitzer B McDonough BJ Maron SA Casey JG Seidman SD Solomon, Circulation 2002 105 2992 2997 10.1161/01.CIR.0000019070.70491.6D 12081993
10. Diastolic abnormalities as the first feature of hypertrophic cardiomyopathy in Dutch myosin-binding protein C founder mutations. M Michels OI Soliman MJ Kofflard YM Hoedemaekers D Dooijes D Majoor-Krakauer FJ ten Cate, JACC Cardiovasc Imaging 2009 2 58 64 10.1016/j.jcmg.2008.08.003 19356534
11. Timing of cardiac contraction in humans mapped by high-temporal- resolution MRI tagging: early onset and late peak of shortening in lateral wall. JJ Zwanenburg MJ Gotte JP Kuijer RM Heethaar AC van Rossum JT Marcus, Am J Physiol Heart Circ Physiol 2004 286 1872 H1880 10.1152/ajpheart.01047.2003 14726304
12. Structural abnormalities of the inferoseptal left ventricular wall detected by cardiac magnetic resonance imaging in carriers of hypertrophic cardiomyopathy mutations. T Germans AA Wilde PA Dijkmans W Chai O Kamp YM Pinto AC van Rossum, J Am Coll Cardiol 2006 48 2518 2523 10.1016/j.jacc.2006.08.036 17174192
13. Effects of aging on left atrioventricular coupling and left ventricular filling assessed using cardiac magnetic resonance imaging in healthy subjects. T Germans MJ Gotte R Nijveldt MD Spreeuwenberg AM Beek JG Bronzwaer CA Visser WJ Paulus van Rossum, Am J Cardiol 2007 100 122 127 10.1016/j.amjcard.2007.02.060 17599453
14. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. RJ Kim DS Fieno TB Parrish K Harris EL Chen O Simonetti J Bundy JP Finn FJ Klocke RM Judd, Circulation 1999 100 1992 2002 10556226
15. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. MD Cerqueira NJ Weissman V Dilsizian AK Jacobs S Kaul WK Laskey DJ Pennell JA Rumberger T Ryan MS Verani American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging, Int J Cardiovasc Imaging 2002 18 539 542 12135124
16. Left ventricular fibre architecture in man. RA Greenbaum SY Ho DG Gibson AE Becker RH Anderson, Br Heart J 1981 45 248 263 10.1136/hrt.45.3.248 7008815
17. Statistical methods for assessing agreement between two methods of clinical measurement. JM Bland DG Altman, Lancet 1986 1 307 310 2868172
18. Semi-quantitative assessment of right ventricular function in comparison to a 3D volumetric approach: a cardiovascular magnetic resonance study. R Nijveldt T Germans GP McCann AM Beek AC van Rossum, Eur Radiol 2008 18 2399 2405 10.1007/s00330-008-1017-7 18523785
19. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. JA Hanley BJ McNeil, Radiology 1983 148 839 843 6878708
20. Variable clinical manifestation of a novel missense mutation in the alpha-tropomyosin (TPM1) gene in familial hypertrophic cardiomyopathy. RJ Jongbloed CL Marcelis PA Doevendans JM Schmeitz-Mulkens WG Van Dockum JP Geraedts HJ Smeets, J Am Coll Cardiol 2003 41 981 986 10.1016/S0735-1097(02) 03005-X 12651045
21. The 2373insG mutation in the MYBPC3 gene is a founder mutation, which accounts for nearly one-fourth of the HCM cases in the Netherlands. M Alders R Jongbloed W Deelen WA van den P Doevendans CF Ten V Regitz-Zagrosek HP Vosberg I van Langen A Wilde D Dooijes M Mannens, Eur Heart J 2003 24 1848 1853 10.1016/S0195-668X(03)00466-4 14563344
22. Normal human left and right ventricular dimensions for MRI as assessed by turbo gradient echo and steady-state free precession imaging sequences. K Alfakih S Plein H Thiele T Jones JP Ridgway MU Sivananthan, J Magn Reson Imaging 2003 17 323 329 10.1002/jmri.10262 12594722
23. Tissue Doppler imaging predicts the development of hypertrophic cardiomyopathy in subjects with subclinical disease. SF Nagueh J McFalls D Meyer R Hill WA Zoghbi JW Tam MA Quĩones R Roberts AJ Marian, Circulation 2003 108 395 398 10.1161/01.CIR.0000084500.72232.8D 12860897
24. Length and protein kinase A modulations of myocytes in cardiac myosin binding protein C-deficient mice. O Cazorla S Szilagyi N Vignier G Salazar E Kramer G Vassort L Carrier A Lacampagne, Cardiovasc Res 2006 69 370 380 10.1016/j.cardiores.2005.11.009 16380103
25. Dilated and Hypertrophic Cardiomyopathy Mutations in Troponin and alpha-Tropomyosin Have Opposing Effects on the Calcium Affinity of Cardiac Thin Filaments. P Robinson PJ Griffiths H Watkins CS Redwood, Circ Res 2007 101 1266 1273 10.1161/CIRCRESAHA.107.156380 17932326
26. Differential roles of cardiac myosin-binding protein C and cardiac troponin I in the myofibrillar force responses to protein kinase A phosphorylation. JE Stelzer JR Patel JW Walker RL Moss, Circ Res 2007 101 503 511 10.1161/CIRCRESAHA.107.153650 17641226
27. Gadolinium-enhanced magnetic resonance imaging for detection and quantification of fibrosis in human myocardium in vitro. E Kehr M Sono SS Chugh M Jerosch-Herold, Int J Cardiovasc Imaging 2008 24 61 68 10.1007/s10554-007- 9223-y 17429755
28. Delayed contrast enhancement and perfusable tissue index in hypertrophic cardiomyopathy: comparison between cardiac MRI and PET. P Knaapen WG van Dockum O Bondarenko WE Kok MJ Gotte R Boellaard AM Beek CA Visser AC van Rossum AA Lammertsma FC Visser, J Nucl Med 2005 46 923 929 15937301
29. Differences in diagnostic value of four electrocardiographic voltage criteria for hypertrophic cardiomyopathy in a genotyped population. T Konno M Shimizu H Ino N Fujino K Hayashi K Uchiyama T Kaneda M Inoue T Fujita E Masuta A Funada H Mabuchi, Am J Cardiol 2005 96 1308 1312 10.1016/j.amjcard.2005.06.078 16253604
30. Late gadolinium enhancement cardiovascular magnetic resonance in genotyped hypertrophic cardiomyopathy with normal phenotype. B Strijack V Ariyarajah R Soni DS Jassal CR Greenberg R McGregor A Morris, J Cardiovasc Magn Reson 2008 10 58 10.1186/1532-429X-10-58 19087273